Monthly Archives: June 2021

FDA must ban sales of illegal regenerative medicine products

[ad_1] The Food and Drug Administration has promised that after May 31, 2021, the agency will broadly enforce requirements that developers of regenerative medicine products – therapies intended to repair or replace damaged cells, tissues and organs – follow relevant approval rules for new drugs , medical devices and biological …

Read More »